Sensyne Health PLC
LSE:SENS
EV/FCFF
Enterprise Value to FCFF
Enterprise Value to Free Cash Flow To Firm (EV/FCFF) ratio is a valuation multiple that compares the value of a company, debt included, to the amount of free cash flow available for all stakeholders. This metric is very similar to the EV/OCF but is considered a more exact measure, owing to the fact that it uses free cash flow, which subtracts capital expenditures (CapEx) from a company's operating cash flow.
Market Cap | EV/FCFF | ||||
---|---|---|---|---|---|
UK |
Sensyne Health PLC
LSE:SENS
|
576.8k GBP | 0.2 | ||
US |
Veeva Systems Inc
NYSE:VEEV
|
33.9B USD | 33.7 | ||
US |
Cerner Corp
NASDAQ:CERN
|
27.9B USD | 25.3 | ||
US |
Change Healthcare Inc
NASDAQ:CHNG
|
9B USD | 35.2 | ||
AU |
Pro Medicus Ltd
ASX:PME
|
11.8B AUD | 179.4 | ||
JP |
M3 Inc
TSE:2413
|
1.1T JPY | 17.8 | ||
US |
Doximity Inc
NYSE:DOCS
|
5.3B USD | 25.5 | ||
US |
Inspire Medical Systems Inc
NYSE:INSP
|
4.7B USD | 1 286.2 | ||
SE |
Sectra AB
STO:SECT B
|
45.7B SEK | 139.6 | ||
US |
Vocera Communications Inc
NYSE:VCRA
|
2.8B USD | 65.5 | ||
US |
Goodrx Holdings Inc
NASDAQ:GDRX
|
2.7B USD | 32.7 |
EV/FCFF Forward Multiples
Forward EV/FCFF multiple is a version of the EV/FCFF ratio that uses forecasted free cash flow to firm for the EV/FCFF calculation. 1-Year, 2-Years, and 3-Years forwards use free cash flow to firm forecasts for 1, 2, and 3 years ahead, respectively.